Deutsche Bank plans airbag phoenix autocallables linked to Cubist Pharmaceuticals

By Susanna Moon

Chicago, Sept. 11 – Deutsche Bank AG, London Branch plans to price airbag phoenix autocallable optimization securities due March 18, 2016 linked to Cubist Pharmaceuticals Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent monthly coupon at an annual rate of 7.5% to 9.5% if the stock closes at or above the 75% coupon barrier level on an observation date for the month.

The notes will be called at par plus accrued interest if Cubist Pharmaceuticals stock closes at or above the initial share price on any quarterly observation date.

The payout at maturity will be par unless the final share price is less than the conversion price, in which case the payout will be a number of Cubist Pharmaceuticals shares equal to $1,000 divided by the conversion price. The conversion price is 85% of the initial share price.

UBS Financial Services Inc. and Deutsche Bank Securities Inc. are the agents.

The notes are expected to price on Sept. 12 and settle on Sept. 17.

The Cusip number is 25190A609.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.